FMP

FMP

Enter

SLRX - Salarius Pharmaceuti...

photo-url-https://images.financialmodelingprep.com/symbol/SLRX.png

Salarius Pharmaceuticals, Inc.

SLRX

NASDAQ

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. The company is headquartered in Houston, Texas.

2.69 USD

0.07 (2.6%)

Earnings

-60-50-40-30-20-1002023 Q12023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q4EPS Consensus

Dividends

We are unable to load the chart at this time.

fmp-logo

Splits

00.030.060.090.120.15Jul 22, 2019Oct 17, 2022Jun 17, 2024

From:

To:

Date

Revenue

Earnings

Estimated Earnings

Surprise

2024-11-14

0

-0.76

-2.4

-68.33%

2024-08-09

0

-2.37

-53.6

-95.58%

2024-05-13

0

-3.28

-53.6

-93.88%

2024-03-22

0

-1.76

-8.08

-78.22%

2023-11-09

0

-0.65

-1.07

-39.25%

2023-08-10

0

-1.43

-1.26

13.49%

2023-05-11

0

-2.23

-1.98

12.63%

2023-03-27

0

-2.83

-2.07

36.71%

2022-11-10

0

-2.47

-2.85

-13.33%

2022-08-08

0

-2.25

-2.75

-18.18%

2022-05-12

0

-3.25

-2.25

44.44%

2022-03-10

-1.84M

-2.25

-2.5

-10.00%

2021-11-04

0

-2

-2.25

-11.11%

2021-08-05

571.39k

-1.75

-1.5

16.67%

2021-05-12

1.27M

-1.5

-1.25

20.00%

2021-03-18

1.48M

-2.5

0

-

2020-11-11

1.38M

-2.5

-2.5

0.00%

2020-08-12

1.24M

-3.25

-4

-18.75%

2020-05-14

1.13M

-5.5

-11

-50.00%

2020-03-23

1.04M

-0.44

0

-

2019-11-13

874.95k

-26

0

-

2019-07-17

164.71k

-50

0

-

2019-03-31

104.98k

-77.16

0

-

2019-03-06

163k

-69.5

0

-

2018-11-05

250.99k

-91.27

0

-

2018-08-01

245.5k

-312.5

-281.25

11.11%

2018-05-02

178.58k

-287.5

-303.12

-5.15%

2018-03-07

283k

-287.5

-356.25

-19.30%

2017-11-06

413.6k

-337.5

-378.12

-10.74%

2017-08-02

335.52k

-318.75

-359.37

-11.30%

2017-05-03

242.55k

-262.5

-387.5

-32.26%

2017-03-08

299k

-250

-462.5

-45.95%

2016-11-02

599.07k

-406.25

-452.08

-10.14%

2016-08-03

112.69k

-443.75

-419.79

5.71%

2016-05-04

0

-381.25

-352.5

8.16%

2016-03-08

0

-318.75

-352.5

-9.57%

2015-11-04

0

-331.25

-276.25

19.91%

2015-08-05

0

-293.75

-228.12

28.77%

2015-05-06

0

-368.75

-181.25

103.45%

2015-02-04

0

-137.41

-3.5

3826.05%

2014-09-30

0

-219.74

0

-

2014-06-30

0

-242.22

0

-

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep